Latest News
Compliance Monitoring Process the MHRA’s new role
Compliance Monitoring Process – from April this year the MHRA are piloting a different approach to the monitoring of companies that are referred to the MHRA’s IAG (Inspection Action Group) for failure to comply with the standards of Good Manufacturing Practice or Good Distribution Practice.
Drug repurposing in the fight against SARS-CoV-2
Drug repurposing offers the possibility of a huge untapped source of safe and effective therapies for both common and rare conditions.
National Patient Safety Alert: Fears over Safety of Potassium Permanganate Use
t National Patient Safety Team, and the British Association of Dermatologists, on the risk of inadvertent oral administration of potassium permanganate and the fear over safety when used.